![Russell Cox](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Cox
Director/Board Member at
GOSSAMER BIO, INC.
Net worth: 1 114 $ as of 2026-09-29
Profile
Russell J.
Cox is Executive Chairman at Epirium Bio, Inc. since 2025.
Mr. Cox is Director at Vascular Cures since 2013.
Mr. Cox is Independent Director at Gossamer Bio, Inc. since 2018.
Formerly, Mr. Cox was Chief Executive Officer & Director at Vital Therapies, Inc. from 2018 to 2019.
Formerly, Mr. Cox was Co-Chief Executive Officer & Director at Immunic, Inc. from 2018 to 2019.
Formerly, Mr. Cox was Chairman at Spyre Therapeutics, Inc. from 2019 to 2024.
Formerly, Mr. Cox was Group Product Manager at Genentech, Inc. from 1987 to 1999.
Formerly, Mr. Cox was Vice President-Marketing at Scios, Inc. from 2003 to 2007.
Formerly, Mr. Cox was Vice President-Marketing at Tercica, Inc. from 2007 to 2008.
Formerly, Mr. Cox was Chief Commercial Officer & EVP at Jazz Pharmaceuticals, Inc. in 2013.
Formerly, Mr. Cox was Chief Commercial Officer & Senior Vice President at Ipsen, Inc. from 2009 to 2010.
Formerly, Mr. Cox was Chief Operating Officer & Executive Vice President at Jazz Pharmaceuticals Plc from 2014 to 2018.
Mr. Cox completed undergraduate education at Texas A&M University in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-22 | 94 ( 0% ) | 1 114 $ | 2026-09-29 |
Russell Cox active positions
| Companies | Position | Start |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 2018-12-18 |
Vascular Cures
 Vascular Cures Miscellaneous Commercial ServicesCommercial Services Operates as voluntary health organization | Director/Board Member | 2012-12-31 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Chairman | 2024-12-31 |
Former positions of Russell Cox
| Companies | Position | End |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Chairman | 2024-05-12 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Chief Executive Officer | 2019-01-24 |
| IMMUNIC, INC. | Chief Executive Officer | 2018-12-31 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Chief Operating Officer | 2018-01-02 |
| JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 2018-01-02 |
Education of Russell Cox
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Manufactures thermal processing equipment and systems | Producer Manufacturing |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Vascular Cures
Vascular Cures Miscellaneous Commercial ServicesCommercial Services Operates as voluntary health organization | Commercial Services |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Russell Cox
